Return On Equity of Intellia Therapeutics, Inc. from 30 Sep 2016 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Intellia Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2016 to 31 Dec 2025.
  • Intellia Therapeutics, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -57%, a 4.8% decline year-over-year.
  • Intellia Therapeutics, Inc. annual Return On Equity for 2025 was -57%, a 4.8% decline from 2024.
  • Intellia Therapeutics, Inc. annual Return On Equity for 2024 was -54%, a 23% decline from 2023.
  • Intellia Therapeutics, Inc. annual Return On Equity for 2023 was -44%, a 9.8% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Intellia Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -57% -2.6% -4.8% 01 Oct 2025 31 Dec 2025
Q3 2025 -57% -5.3% -10% 01 Jul 2025 30 Sep 2025
Q2 2025 -58% -8% -16% 01 Apr 2025 30 Jun 2025
Q1 2025 -59% -13% -28% 01 Jan 2025 31 Mar 2025
Q4 2024 -54% -10% -23% 01 Oct 2024 31 Dec 2024
Q3 2024 -52% -11% -28% 01 Jul 2024 30 Sep 2024
Q2 2024 -50% -8.1% -19% 01 Apr 2024 30 Jun 2024
Q1 2024 -46% -4.3% -10% 01 Jan 2024 31 Mar 2024
Q4 2023 -44% +4.8% +9.8% 01 Oct 2023 31 Dec 2023
Q3 2023 -40% +7.3% +15% 01 Jul 2023 30 Sep 2023
Q2 2023 -42% -1.4% -3.5% 01 Apr 2023 30 Jun 2023
Q1 2023 -42% -0.67% -1.6% 01 Jan 2023 31 Mar 2023
Q4 2022 -49% -15% -45% 01 Oct 2022 31 Dec 2022
Q3 2022 -48% -14% -40% 01 Jul 2022 30 Sep 2022
Q2 2022 -40% -1.2% -3.1% 01 Apr 2022 30 Jun 2022
Q1 2022 -41% -7.1% -21% 01 Jan 2022 31 Mar 2022
Q4 2021 -34% +3.3% +8.8% 01 Oct 2021 31 Dec 2021
Q3 2021 -34% +5.9% +15% 01 Jul 2021 30 Sep 2021
Q2 2021 -39% +1.6% +3.8% 01 Apr 2021 30 Jun 2021
Q1 2021 -34% +7% +17% 01 Jan 2021 31 Mar 2021
Q4 2020 -37% -0.24% -0.66% 01 Oct 2020 31 Dec 2020
Q3 2020 -40% -7.1% -22% 01 Jul 2020 30 Sep 2020
Q2 2020 -41% -7.5% -23% 01 Apr 2020 30 Jun 2020
Q1 2020 -41% -9.2% -29% 01 Jan 2020 31 Mar 2020
Q4 2019 -37% -6% -20% 01 Oct 2019 31 Dec 2019
Q3 2019 -33% -1.3% -4.1% 01 Jul 2019 30 Sep 2019
Q2 2019 -33% -1.5% -4.7% 01 Apr 2019 30 Jun 2019
Q1 2019 -32% +0.11% +0.35% 01 Jan 2019 31 Mar 2019
Q4 2018 -31% +0.68% +2.2% 01 Oct 2018 31 Dec 2018
Q3 2018 -32% -3.7% -13% 01 Jul 2018 30 Sep 2018
Q2 2018 -32% -8.8% -39% 01 Apr 2018 30 Jun 2018
Q1 2018 -32% -14% -80% 01 Jan 2018 31 Mar 2018
Q4 2017 -31% -11% -54% 01 Oct 2017 31 Dec 2017
Q3 2017 -28% -1.2% -4.7% 01 Jul 2017 30 Sep 2017
Q2 2017 -23% 01 Apr 2017 30 Jun 2017
Q1 2017 -18% 01 Jan 2017 31 Mar 2017
Q4 2016 -20% 01 Oct 2016 31 Dec 2016
Q3 2016 -27% 01 Jul 2016 30 Sep 2016

Intellia Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -57% -2.6% -4.8% 01 Jan 2025 31 Dec 2025
2024 -54% -10% -23% 01 Jan 2024 31 Dec 2024
2023 -44% +4.8% +9.8% 01 Jan 2023 31 Dec 2023
2022 -49% -15% -45% 01 Jan 2022 31 Dec 2022
2021 -34% +3.3% +8.8% 01 Jan 2021 31 Dec 2021
2020 -37% +138% +79% 01 Jan 2020 31 Dec 2020
2019 -175% -144% -471% 01 Jan 2019 31 Dec 2019
2018 -31% +0.68% +2.2% 01 Jan 2018 31 Dec 2018
2017 -31% -11% -54% 01 Jan 2017 31 Dec 2017
2016 -20% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.